
Healthcare / Medical Devices · NSE / BSE
Founded in 1982, Sanstar Limited is a leading Indian manufacturer of specialty plant-based products and ingredient solutions for food, pet food, and industrial applications. Its extensive product portfolio includes liquid glucose, dried glucose solids, maltodextrin powder, dextrose monohydrate, native and modified maize starches, and by-products such as germ, gluten, fiber, and fortified proteins, serving as thickeners, stabilizers, sweeteners, emulsifiers, and functional additives. The company operates two manufacturing facilities in Dhule, Maharashtra, and Kutch, Gujarat, covering 10.68 million sq. ft. with an installed capacity of 363,000 tons per annum, making it India’s fifth-largest corn-based specialty ingredients producer. Sanstar exports to 49 countries across Asia, Africa, the Middle East, America, Europe, and Oceania, with a pan-India presence in 22 states, and as of March 31, 2024, employs 271 people, including 60 permanent staff.
Price Band
₹90 – ₹95
Issue Size
₹510 Cr
Lot Size
150 shares
GMP
+26.3%
Est. Listing
₹120
at current GMP
Subscribed
82.98x
overall
Open
19 Jul 2024
Close
23 Jul 2024
Allotment
24 Jul 2024
Refund
25 Jul 2024
Demat Credit
26 Jul 2024
Listing
26 Jul 2024
Overall Subscription
82.98x
Total Demand
QIB Multiplier
145.68x
Institutions & Funds
NII / HNI
136.49x
High Net-Worth
Retail (RII)
24.23x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 10,740,000 | 1,564,582,800 | 145.68x |
| NIB | 8,055,000 | 1,099,452,900 | 136.49x |
| HNIs(10L +) | 5,370,000 | 802,484,550 | 149.44x |
| HNIs (2-10L) | 2,685,000 | 296,968,350 | 110.60x |
| RETAIL | 18,795,000 | 455,352,450 | 24.23x |
| Total | 45,645,000 | 4,218,841,050 | 82.98x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 125,300 | 3,036,019 | 24.23x |
| HNIs (10L +) | 801 | 109,328 | 136.49x |
| HNIs (2-10L) | 3,836 | 523,576 | 136.49x |
| Total Applications | 129,937 | 3,668,923 | 28.24x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Sanstar Limited is bringing an initial public offering (IPO) in the Healthcare / Medical Devices sector with an aggregate issue size of ₹510.15 Crores. The shares are offered at a price band of ₹90 to ₹95 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-07-23, the basis of allotment is scheduled to be finalized on 2024-07-24. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Sanstar Limited IPO is ₹25 per equity share. Based on the upper price band of ₹90 to ₹95 per equity share, the estimated listing price is ₹120 (+26.3% expected listing gain).
With a lot size of 150 shares and current GMP of ₹25, the expected profit per application lot is approx ₹3,750 (+26.3% gain). Minimum application cost is approx ₹14,250.
The Sanstar Limited IPO aggregate issue size is ₹510.15 Crores with an equity price band set at ₹90 to ₹95 per equity share. The retail lot size is 150 shares requiring a minimum capital outlay of approx. ₹14,250.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 82.98x (Retail: 24.23x, QIB: 145.68x, NII: 136.49x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Link Intime India Private Limited) and the BSE status verification website on or around 2024-07-24. Investors can verify status using PAN card or application number.
Sanstar Limited shares are scheduled to list on NSE and BSE on 2024-07-26.